Breaking News Instant updates and real-time market news.

CRSP

Crispr Therapeutics

$18.72

-0.08 (-0.43%)

08:32
10/13/17
10/13
08:32
10/13/17
08:32

Crispr Therapeutics awarded grant from FARA

CRISPR Therapeutics announced the receipt of the Kyle Bryant Translational Research Award from Friedreich's Ataxia Research Alliance, or FARA, a non-profit organization that is focused on curing Friedreich's Ataxia, or FA. The grant is awarded to fund research on in vivo CRISPR/Cas9-based gene-editing approaches to treat FA, which will be performed in collaboration with Dr. Marek Napierala at University of Alabama at Birmingham. This announcement coincides with FARA's rideATAXIA Philadelphia event, a lead location in an annual bike ride program founded by patient Kyle Bryant, that increases FA awareness and raises funds to treat and cure FA through research. Under the terms of the grant, CRISPR Therapeutics will develop gene-editing reagents with the potential to address the underlying genetic causes of FA. Dr. Napierala and colleagues will then evaluate the reagents in humanized animal models of FA to demonstrate preclinical proof-of-concept. Upon conclusion of these studies, CRISPR Therapeutics will have the option to advance the compounds into clinical trials.

CRSP Crispr Therapeutics
$18.72

-0.08 (-0.43%)

03/28/17
CHDN
03/28/17
INITIATION
Target $23.5
CHDN
Buy
CRISPR Therapeutics initiated with a Buy at Chardan
Chardan analyst Madhu Kumar initiated CRISPR Therapeutics with a Buy and a $23.50 price target saying upside from clinical leadership in CRISPR therapy offsets any potential downside from its IP exposure.
07/13/17
RHCO
07/13/17
INITIATION
Target $16
RHCO
Hold
CRISPR Therapeutics initiated with a Hold at SunTrust
SunTrust analyst Peter Larson initiated CRISPR Therapeutics with a Hold and a $16 price target.
07/17/17
OPCO
07/17/17
INITIATION
OPCO
Perform
Crispr Therapeutics initiated with a Perform at Oppenheimer
Oppenheimer analyst Leah Rush Cann started Crispr Therapeutics (CRSP) with a Perform rating saying the company is in a weaker patent position than competitor Editas Medicine (EDIT).
09/06/17
LEHM
09/06/17
INITIATION
LEHM
Overweight
Crispr Therapeutics assumed with an Overweight at Barclays
Barclays assumed Crispr with an Overweight rating and a $29 price target, up from $22, citing substantial upside as "more clinical data are generated from CRSP/NTLA/EDIT to further support broad application of CRISPR/Cas9 technology."

TODAY'S FREE FLY STORIES

SYNT

Syntel

$24.30

5.2 (27.23%)

20:37
10/17/17
10/17
20:37
10/17/17
20:37
Upgrade
Syntel rating change at William Blair »

Syntel upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 14

    Dec

QD

Qudian

20:35
10/17/17
10/17
20:35
10/17/17
20:35
Syndicate
Qudian 37.5M share IPO priced at $24.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ABT

Abbott

$55.06

0.43 (0.79%)

, USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

20:25
10/17/17
10/17
20:25
10/17/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$55.06

0.43 (0.79%)

USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

SVU

Supervalu

$19.38

0.57 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 17

    Jan

UNH

UnitedHealth

$203.89

10.69 (5.53%)

19:58
10/17/17
10/17
19:58
10/17/17
19:58
Recommendations
UnitedHealth analyst commentary at Piper Jaffray »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

19:25
10/17/17
10/17
19:25
10/17/17
19:25
Conference/Events
The Heritage Foundation hosts President Trump »

President Trump speaks at…

SINA

Sina

$114.26

-0.73 (-0.63%)

19:18
10/17/17
10/17
19:18
10/17/17
19:18
Hot Stocks
Aristeia: Sina claims 'inaccurate' and 'misleading' »

Aristeia Capital, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CLDR

Cloudera

$15.51

0.13 (0.85%)

, HTHIY

Hitachi

$75.56

-0.49 (-0.64%)

18:57
10/17/17
10/17
18:57
10/17/17
18:57
Hot Stocks
Cloudera, Hitachi form strategic partnership »

Cloudera (CLDR) announced…

CLDR

Cloudera

$15.51

0.13 (0.85%)

HTHIY

Hitachi

$75.56

-0.49 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$65.15

-1.15 (-1.73%)

18:35
10/17/17
10/17
18:35
10/17/17
18:35
Earnings
Pinnacle Financial reports Q3 adjusted EPS 90c, consensus 74c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

FULT

Fulton Financial

$18.95

-0.3 (-1.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Fulton Financial sees FY17 loans & deposits growth mid to high single digits »

Sees FY17 non-interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 01

    Nov

  • 02

    Nov

EXXI

Energy XXI

$8.59

-0.41 (-4.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Energy XXI provides operational update on Hurricane Nate impact »

Energy XXI provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$18.95

-0.3 (-1.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Fulton Financial cuts Q4 net interest margin view to up 2-6 bp from 3-9 »

Cuts Q4 non-interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 01

    Nov

  • 02

    Nov

HGV

Hilton Grand Vacations

$39.83

0.05 (0.13%)

17:45
10/17/17
10/17
17:45
10/17/17
17:45
Hot Stocks
Hilton Grand Vacations acquires Sunrise Lodge, terms not disclosed »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

PRGX

PRGX Global

$6.80

0.05 (0.74%)

, KR

Kroger

$20.48

0.04 (0.20%)

17:42
10/17/17
10/17
17:42
10/17/17
17:42
Hot Stocks
PRGX Global signs multi-year technology services contract with Kroger »

PRGX Global (PRGX) signed…

PRGX

PRGX Global

$6.80

0.05 (0.74%)

KR

Kroger

$20.48

0.04 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 14

    Dec

UBFO

United Security Bank

$9.50

-0.05 (-0.52%)

17:38
10/17/17
10/17
17:38
10/17/17
17:38
Earnings
United Security Bank reports Q3 EPS 16c versus 12c in year-ago period »

Reports Q3 NII $8.2M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSH

Union Bankshares

$35.32

-0.18 (-0.51%)

, XBKS

Xenith Bankshares

$32.77

-0.07 (-0.21%)

17:35
10/17/17
10/17
17:35
10/17/17
17:35
Hot Stocks
Xenith Bankshares merger into Union Bankshares receives regulatory approval »

Union Bankshares (UBSH)…

UBSH

Union Bankshares

$35.32

-0.18 (-0.51%)

XBKS

Xenith Bankshares

$32.77

-0.07 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

OMAB

OMA Airports

$41.34

0.28 (0.68%)

17:35
10/17/17
10/17
17:35
10/17/17
17:35
Hot Stocks
OMA Airports reports Q3 terminal passenger traffic up 1.3% »

Aeronautical revenues per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$146.54

-0.29 (-0.20%)

17:34
10/17/17
10/17
17:34
10/17/17
17:34
Earnings
IBM sees $2.8B-$2.9B increase in Q4 sales from Q3 »

Sees $300M-$400M boost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

OMAB

OMA Airports

$41.34

0.28 (0.68%)

17:33
10/17/17
10/17
17:33
10/17/17
17:33
Earnings
OMA Airports reports Q3 EPS 66c, consensus 70c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

17:33
10/17/17
10/17
17:33
10/17/17
17:33
Hot Stocks
Breaking Hot Stocks news story on Select Comfort »

Select Comfort says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

, IBKR

Interactive Brokers

$47.40

-0.32 (-0.67%)

17:32
10/17/17
10/17
17:32
10/17/17
17:32
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: IBM…

IBM

IBM

$146.54

-0.29 (-0.20%)

IBKR

Interactive Brokers

$47.40

-0.32 (-0.67%)

SSKN

STRATA Skin Sciences

$1.75

-0.04 (-2.23%)

HCLP

Hi-Crush Partners

$8.95

0.25 (2.87%)

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

NAVI

Navient

$12.20

0.47 (4.01%)

CREE

Cree

$29.34

0.06 (0.20%)

AKTX

Akari Therapeutics

$6.40

-0.08 (-1.23%)

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

FOGO

Fogo De Chao

$12.05

0.1 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 22

    Oct

  • 01

    Nov

  • 15

    Nov

  • 18

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

17:32
10/17/17
10/17
17:32
10/17/17
17:32
Hot Stocks
IBM sees increase in gross margin of 2.5 points from Q3 to Q4 »

Says not yet feeling full…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

PAYX

Paychex

$62.90

-0.55 (-0.87%)

17:31
10/17/17
10/17
17:31
10/17/17
17:31
Syndicate
Breaking Syndicate news story on Paychex »

Paychex files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

VZ

Verizon

$48.40

0.31 (0.64%)

17:24
10/17/17
10/17
17:24
10/17/17
17:24
Hot Stocks
FCC settles New York City E-rate investigation with Verizon »

The Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

17:20
10/17/17
10/17
17:20
10/17/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Select Comfort »

Select Comfort expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

17:17
10/17/17
10/17
17:17
10/17/17
17:17
Hot Stocks
IBM: Global business services signings up for 3rd consecutive quarter »

Says cognitive solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.